Last Updated on August 30, 2024 by admin
Introducing MYCOFIT 500MG TABLET
Organ transplantation has revolutionized the field of medicine, offering a new lease on life for patients suffering from end-stage organ failure. However, the success of these life-saving procedures depends on preventing organ rejection, a complex immune response that can threaten the viability of the transplanted organ. In this article, we introduce MYCOFIT 500MG TABLET, a groundbreaking medication designed to prevent organ rejection and improve the long-term outcomes of transplant patients.
Understanding Organ Rejection
When a patient undergoes an organ transplant, the immune system recognizes the transplanted organ as foreign and launches an attack to eliminate it. This immune response, known as organ rejection, can occur in various forms, including hyperacute rejection, acute rejection, and chronic rejection. To prevent this potentially life-threatening reaction, transplant patients require immunosuppressive medications.
The Role of MYCOFIT 500MG TABLET
MYCOFIT 500MG TABLET is a powerful immunosuppressive medication that plays a crucial role in preventing organ rejection. It contains the active ingredient Mycophenolate Mofetil, which works by suppressing the activity of certain immune cells responsible for initiating the rejection process. By inhibiting the immune response, MYCOFIT 500MG TABLET helps to maintain the function and longevity of the transplanted organ.
Key Benefits of MYCOFIT 500MG TABLET
1. Enhanced Patient Survival: MYCOFIT 500MG TABLET has been shown to significantly improve patient survival rates following organ transplantation. By reducing the risk of organ rejection, this medication allows patients to enjoy a better quality of life and increased longevity.
2. Lower Incidence of Rejection Episodes: MYCOFIT 500MG TABLET helps to minimize the occurrence of acute rejection episodes, which can be detrimental to the transplanted organ. By providing consistent immunosuppression, this medication reduces the likelihood of rejection and the need for additional medical interventions.
3. Improved Graft Function: MYCOFIT 500MG TABLET supports optimal graft function by preventing the immune system from attacking the transplanted organ. This leads to improved organ function, reduced risk of complications, and increased overall transplant success.
Usage and Dosage
MYCOFIT 500MG TABLET should be taken exactly as prescribed by the healthcare professional. The dosage may vary depending on factors such as the type of transplant, patient’s weight, and other individual considerations. It is important to follow the prescribed dosage and schedule to ensure the maximum effectiveness of the medication.
About Mycofit 500 Tablet
SALT COMPOSITION
Mycophenolate mofetil (500mg)
Mycofit 500 Tablet belongs to a group of medicines called immunosuppressants. It is used with other medicines to prevent your body from rejecting an organ (such as a kidney, heart or liver) after a transplant. It works by supressing your body’s immune system, so that it does not attack the new organ.
The amount of Mycofit 500 Tablet you take and how often you take it depends on the type of transplant you have. Follow your doctor’s instructions on this. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Swallow it as a whole, do not crush, chew, or break it. Take the medicine regularly to get the maximum benefit and keep taking it even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ. The treatment will continue for as long as you need it to prevent rejection.
You may catch more infection than usual as medicine suppresses the immune system. There is also an increased risk of developing some cancers for this reason. To reduce your risk of skin cancer, limit your exposure to the sun and use sunscreen. There is a long list of potential side effects with this medicine. You should ask your doctor about them and what signs to look out for because some of them can be serious and need urgent medical attention.
Mycofit 500 Tablet can cause birth defects and abortion so do not take it if you are pregnant, planning to become pregnant or breastfeeding. You should talk to your doctor before taking this medicine if you have any signs of infection or if you have any unexpected bruising or bleeding. You should also let your healthcare team know all other medicines you are taking as they may affect, or be affected by, this medicine. You will have regular tests to check for any changes in the number of your blood cells and the amount of sugar and cholesterol in your blood.
USE OF MYCOFIT TABLETS
BENEFITS OF MYCOFIT TABLET
- In Prevention of organ rejection in transplant patients
Mycofit 500 Tablet belongs to a group of medicines known as immunosuppressive agents. It lowers your immune response and reduces the chance of your body attacking the transplanted organ. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine may be used in combination with other medicines to suppress the immune system and help your body accept the new organ.
SIDE EFFECTS OF MYCOFIT TABLET
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mycofit
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- High blood pressure
- Decreased white blood cell count (neutrophils)
HOW TO USE MYCOFIT TABLET
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mycofit 500 Tablet may be taken with or without food, but it is better to take it at a fixed time.
HOW MYCOFIT TABLET WORKS
Mycofit 500 Tablet is an immunosuppressant. It reduces the action of body’s own defence system (the immune system) and prevents rejection of the transplanted organ.
SAFETY ADVICE
warnings
Alcohol
SAFE
Consuming alcohol with Mycofit 500 Tablet does not cause any harmful side effects.
warnings
Pregnancy
CONSULT YOUR DOCTOR
Mycofit 500 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
warnings
Breastfeeding
UNSAFE
Mycofit 500 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
warnings
Driving
SAFE
Mycofit 500 Tablet does not usually affect your ability to drive.
warnings
Kidney
SAFE IF PRESCRIBED
Mycofit 500 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Mycofit 500 Tablet may not be needed in these patients. Please consult your doctor.
warnings
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Mycofit 500 Tablet in patients with liver disease. Please consult your doctor.
warning
CHILDREN CAUTION
UNSAFE
Mycofit 500 Tablet is not recommended for use in children and adolescents below 18 years.
Mycofit 500 Tablet Habit Forming : NO
expert advice
- Your doctor has prescribed Mycofit 500 Tablet to stop your body from rejecting a transplanted organ (e.g. kidney, heart or liver).
- It may take 6 to 12 weeks for Mycofit 500 Tablet to start working. Keep taking it as prescribed.
- It may cause birth defects so birth control is required in females with reproductive potential.
- It makes you more susceptible to getting infections. Avoid contact with people who have an infection. Consult your doctor immediately if you develop a sore throat, high temperature, any other signs of infections.
- Protect yourself from direct sunlight by wearing protective clothing and applying a sunscreen with a high sun protection factor (SPF).
- Take it with food to minimize possible side effects like nausea and stomach pain.
- Your doctor may get regular blood tests done to monitor the levels of blood cells in your blood. Inform your doctor if you experience symptoms such as unexplained bruising or bleeding, sore throat, mouth ulcers, or fever.
FAQs ABOUT MYCOFIT 500MG TABLET
Q: What is MYCOFIT 500MG TABLET used for?
A: MYCOFIT 500MG TABLET is used to prevent your body from rejecting an organ transplant (such as kidney, heart, and liver). Contact your doctor before taking MYCOFIT 500MG TABLET.
Q: Can I use MYCOFIT 500MG TABLET in pregnancy?
A: No. MYCOFIT 500MG TABLET is strictly not recommended for use in pregnant women unless considered necessary. Contact your doctor before taking MYCOFIT 500MG TABLET.
Q: Is MYCOFIT 500MG TABLET safe?
A: Yes, MYCOFIT 500MG TABLET is safe and well tolerated. Contact your doctor before taking.
Q: Can I use MYCOFIT 500MG TABLET in children?
A: No, MYCOFIT 500MG TABLET is not recommended for use in children under the age of 2, because there is limited information on its safety and effectiveness for them. Contact your doctor before taking.
Q: How MYCOFIT 500MG TABLET work?
A: MYCOFIT 500MG TABLET belongs to immunosuppressants which reduces the action of the body’s own defense system (the immune system) and prevents rejection of the transplanted organ.
Q: Can I use MYCOFIT 500MG TABLET while breast feeding?
A: No. MYCOFIT 500MG TABLET is generally not recommended for use in breastfeeding women, small amounts of the medicine can pass into the mother’s milk. Contact your doctor before taking it.
Q: what is MYCOFIT 500MG TABLET price?
A: MYCOFIT 500MG TABLET is available at net rate 399 on HIVHUB.IN, which provides free shipping all over India and also gives cash on delivery, MRP of MYCOFIT 500MG TABLET in the market is 775.64.
REFERENCES:
- KD Tripathi. Immunosuppressant Drugs. Essentials of Medical Pharmacology. Seventh Edition,2013. Page – 883.
- Jeffrey J Swigris, Amy L Olson, Aryeh Fischer, David A Lynch, Gregory P Cosgrove, Stephen K Frankel, Richard T Meehan, Kevin K Brown. Uses of Mycophenolate mofetil. National Institute of Health. NLM. National Centre for Biotechnology Information. Pubmed.gov. 2006. [Accessed on 16th July 2022] https://pubmed.ncbi.nlm.nih.gov/16840379/
- Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July 2021] [Accessed 16th July 2022] https://www.medicines.org.uk/emc/files/pil.5560.pdf
- Roche Products Limited. Electronic Medicines Compendium (EMC); [Revised on January 2022] [Accessed 16th July 2022] https://www.medicines.org.uk/emc/files/pil.1102.pdf
- Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July 2021] [Accessed 16th July 2022] https://www.medicines.org.uk/emc/files/pil.7793.pdf
- Accord Healthcare B.V. Electronic Medicines Compendium (EMC); [Revised on Oct 2020] [Accessed 16th July 2022] https://www.medicines.org.uk/emc/files/pil.5989.pdf
- Roche Pharma AG. European Medical Agency. [Revised in Jan 2021] [Accessed on 16th July 2022] https://www.ema.europa.eu/en/documents/product-information/cellcept-epar-product-information_en.pdf
- Biocon. Mycophenolate mofetil. [Accessed on 16th July 2022] https://www.biocon.com/docs/prescribing_information/nephrology/renodapts540_pi.pd
- Hoffmann-La Roche Limited. Mycophenolate mofetil. [Revised on January 2022] [Accessed 16th July 2022] https://www.rochecanada.com/PMs/CellCept/CellCept_PM_E.pdf
- Mycophenolate mofetil. Mims.com. [Accessed on 16th July 2022] https://www.mims.com/india/drug/info/mycophenolic%20acid?type=full&mtype=generic
There are no reviews yet.